1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Patent Number 09125910

US 09125910 B2
Application Number14481000
Publication NumberUS 20150005318 A1
Pendency12 months, 4 days
Filled DateSep 9, 2014
Priority DateJun 16, 2006
Publication DateJan 1, 2015
Expiration DateJun 15, 2026
Inventor/ApplicantsBenny Bang-Andersen
Tine Bryan Stensbol
Nicholas Moore
Andre Faldt
Arne Mork
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Assignments
H. Lundbeck As
Current
H. Lundbeck As
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.